Birdwatch Archive

Birdwatch Note

2024-10-14 13:31:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Listed among the limitations of the study cited in the article is this important caveat: "the population prevalence of pediatric PASC cannot be determined with the current design because participants with more prolonged symptoms may have been more inclined to enroll." https://x.com/onehorseblind/status/1845691495560744996 https://jamanetwork.com/journals/jama/article-abstract/2822770

Written by A02A42E7C76438897E2DA160347364F9E8F3080891948B9EB64B3F64CBA4E348
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1845515745721241810

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1845819628641017993
  • noteId - 1845819628641017993
  • participantId -
  • noteAuthorParticipantId - A02A42E7C76438897E2DA160347364F9E8F3080891948B9EB64B3F64CBA4E348 Participant Details
  • createdAtMillis - 1728912667795
  • tweetId - 1845515745721241810
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Listed among the limitations of the study cited in the article is this important caveat: "the population prevalence of pediatric PASC cannot be determined with the current design because participants with more prolonged symptoms may have been more inclined to enroll." https://x.com/onehorseblind/status/1845691495560744996 https://jamanetwork.com/journals/jama/article-abstract/2822770

Note Ratings

rated at rated by
2024-10-16 11:07:20 -0500 Rating Details
2024-10-16 07:49:08 -0500 Rating Details
2024-10-16 06:50:04 -0500 Rating Details
2024-10-16 02:47:58 -0500 Rating Details
2024-10-15 22:13:57 -0500 Rating Details
2024-10-15 00:39:54 -0500 Rating Details
2024-10-14 23:33:01 -0500 Rating Details
2024-10-14 23:20:31 -0500 Rating Details
2024-10-14 23:01:29 -0500 Rating Details
2024-10-14 17:23:14 -0500 Rating Details
2024-10-14 14:14:33 -0500 Rating Details
2024-10-14 11:01:53 -0500 Rating Details
2024-10-14 09:01:21 -0500 Rating Details
2024-10-14 08:50:47 -0500 Rating Details
2024-10-14 08:42:15 -0500 Rating Details
2024-10-14 08:33:51 -0500 Rating Details
2024-10-21 08:30:19 -0500 Rating Details
2024-10-16 07:33:45 -0500 Rating Details
2024-10-15 03:26:49 -0500 Rating Details
2024-10-15 02:30:42 -0500 Rating Details
2024-10-14 13:07:14 -0500 Rating Details
2024-10-14 12:50:52 -0500 Rating Details
2024-10-14 12:21:07 -0500 Rating Details
2024-10-14 12:18:40 -0500 Rating Details
2024-10-14 11:49:22 -0500 Rating Details
2024-10-14 11:14:11 -0500 Rating Details
2024-10-14 10:32:19 -0500 Rating Details
2024-10-14 09:35:18 -0500 Rating Details
2024-10-14 08:42:28 -0500 Rating Details
2024-10-15 12:55:09 -0500 Rating Details
2024-10-15 11:08:44 -0500 Rating Details
2024-10-15 08:19:28 -0500 Rating Details
2024-10-15 04:50:22 -0500 Rating Details
2024-10-15 02:15:20 -0500 Rating Details
2024-10-14 21:09:29 -0500 Rating Details
2024-10-14 19:56:56 -0500 Rating Details
2024-10-14 19:46:17 -0500 Rating Details
2024-10-14 19:37:13 -0500 Rating Details
2024-10-14 18:15:07 -0500 Rating Details
2024-10-14 16:14:30 -0500 Rating Details
2024-10-14 16:00:56 -0500 Rating Details
2024-10-14 14:27:08 -0500 Rating Details
2024-10-14 11:52:27 -0500 Rating Details
2024-10-14 10:54:10 -0500 Rating Details
2024-10-14 10:48:44 -0500 Rating Details
2024-10-14 10:40:44 -0500 Rating Details
2024-10-14 10:21:12 -0500 Rating Details
2024-10-14 09:06:18 -0500 Rating Details
2024-10-14 08:57:07 -0500 Rating Details
2024-10-18 23:23:01 -0500 Rating Details
2024-10-15 19:32:56 -0500 Rating Details
2024-10-15 00:26:06 -0500 Rating Details
2024-10-14 20:26:59 -0500 Rating Details
2024-10-14 19:29:45 -0500 Rating Details
2024-10-14 19:28:42 -0500 Rating Details
2024-10-14 18:33:51 -0500 Rating Details
2024-10-14 14:49:37 -0500 Rating Details
2024-10-14 14:38:04 -0500 Rating Details
2024-10-14 12:15:58 -0500 Rating Details
2024-10-14 11:38:07 -0500 Rating Details
2024-10-14 11:29:07 -0500 Rating Details
2024-10-14 11:26:21 -0500 Rating Details
2024-10-14 10:39:19 -0500 Rating Details
2024-10-14 10:34:48 -0500 Rating Details
2024-10-14 10:33:14 -0500 Rating Details
2024-10-14 09:16:52 -0500 Rating Details
2024-10-14 08:59:10 -0500 Rating Details
2024-10-14 08:56:58 -0500 Rating Details
2024-10-19 17:10:02 -0500 Rating Details
2024-10-15 21:50:24 -0500 Rating Details
2024-10-15 13:57:49 -0500 Rating Details
2024-10-15 09:28:35 -0500 Rating Details
2024-10-15 03:32:37 -0500 Rating Details
2024-10-15 02:38:00 -0500 Rating Details
2024-10-14 19:43:49 -0500 Rating Details
2024-10-14 18:09:00 -0500 Rating Details
2024-10-14 16:52:40 -0500 Rating Details
2024-10-14 16:39:20 -0500 Rating Details
2024-10-14 15:52:07 -0500 Rating Details
2024-10-14 15:39:57 -0500 Rating Details
2024-10-14 15:30:41 -0500 Rating Details
2024-10-14 13:14:04 -0500 Rating Details
2024-10-14 12:35:12 -0500 Rating Details
2024-10-14 10:48:18 -0500 Rating Details
2024-10-14 10:46:22 -0500 Rating Details
2024-10-14 08:59:31 -0500 Rating Details